Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer
- 30 April 1988
- journal article
- other
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (4) , 801-802
- https://doi.org/10.1016/0277-5379(88)90321-5
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.Journal of Clinical Oncology, 1987
- Epirubicin in colorectal cancerInvestigational New Drugs, 1985
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983